- Home
- FSEA vs DTIL Comparison
FSEA vs DTIL Comparison
Compare FSEA & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- DTIL
- Stock Information
- Founded
- FSEA 1890
- DTIL 2006
- Country
- FSEA United States
- DTIL United States
- Employees
- FSEA N/A
- DTIL N/A
- Industry
- FSEA Savings Institutions
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- DTIL Health Care
- Exchange
- FSEA Nasdaq
- DTIL Nasdaq
- Market Cap
- FSEA 52.8M
- DTIL 51.6M
- IPO Year
- FSEA N/A
- DTIL 2019
- Fundamental
- Price
- FSEA $11.51
- DTIL $5.15
- Analyst Decision
- FSEA
- DTIL Strong Buy
- Analyst Count
- FSEA 0
- DTIL 2
- Target Price
- FSEA N/A
- DTIL $47.00
- AVG Volume (30 Days)
- FSEA 4.0K
- DTIL 242.5K
- Earning Date
- FSEA 08-08-2025
- DTIL 08-04-2025
- Dividend Yield
- FSEA N/A
- DTIL N/A
- EPS Growth
- FSEA N/A
- DTIL N/A
- EPS
- FSEA 0.00
- DTIL N/A
- Revenue
- FSEA $16,196,000.00
- DTIL $51,141,000.00
- Revenue This Year
- FSEA N/A
- DTIL N/A
- Revenue Next Year
- FSEA N/A
- DTIL $53.21
- P/E Ratio
- FSEA $1,512.58
- DTIL N/A
- Revenue Growth
- FSEA 97.61
- DTIL N/A
- 52 Week Low
- FSEA $8.90
- DTIL $3.61
- 52 Week High
- FSEA $11.80
- DTIL $11.09
- Technical
- Relative Strength Index (RSI)
- FSEA 57.13
- DTIL 62.43
- Support Level
- FSEA $11.18
- DTIL $4.51
- Resistance Level
- FSEA $11.75
- DTIL $5.25
- Average True Range (ATR)
- FSEA 0.20
- DTIL 0.32
- MACD
- FSEA 0.03
- DTIL 0.08
- Stochastic Oscillator
- FSEA 67.18
- DTIL 89.80
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.